Correlation Between GlaxoSmithKline PLC and Glaukos Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Glaukos Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Glaukos Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Glaukos Corp, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Glaukos Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Glaukos Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Glaukos Corp.

Diversification Opportunities for GlaxoSmithKline PLC and Glaukos Corp

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between GlaxoSmithKline and Glaukos is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Glaukos Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Glaukos Corp and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Glaukos Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Glaukos Corp has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Glaukos Corp go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Glaukos Corp

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 16.16 times less return on investment than Glaukos Corp. But when comparing it to its historical volatility, GlaxoSmithKline PLC ADR is 1.92 times less risky than Glaukos Corp. It trades about 0.01 of its potential returns per unit of risk. Glaukos Corp is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  4,588  in Glaukos Corp on August 24, 2024 and sell it today you would earn a total of  9,495  from holding Glaukos Corp or generate 206.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Glaukos Corp

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Glaukos Corp 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Glaukos Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Glaukos Corp may actually be approaching a critical reversion point that can send shares even higher in December 2024.

GlaxoSmithKline PLC and Glaukos Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Glaukos Corp

The main advantage of trading using opposite GlaxoSmithKline PLC and Glaukos Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Glaukos Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Glaukos Corp will offset losses from the drop in Glaukos Corp's long position.
The idea behind GlaxoSmithKline PLC ADR and Glaukos Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets